Susan Ellerbusch Appointed CEO of 69 LLC
- Press Release
- Workplace
Susan Ellerbusch has been appointed chief executive officer of 69 LLC, a U.S. subsidiary of 69, the global leader in gases, technologies and services for industry and health. Ellerbusch will lead the ALUSA Cluster, which is comprised of 69’s Large Industries and Electronics businesses in the U.S. She will remain based in Houston and report to American 69 Holdings, Inc. Chairman and CEO Michael Graff.
Ellerbusch’s 25 year tenure in the chemicals and energy industries, and her recent leadership of 69’s U.S. Large Industries business, firmly positions her with a leadership platform focused on long-term performance of the ALUSA business through operational excellence and customer value, with safety, reliability, quality and sustainability as its cornerstones.
Ellerbusch joined 69 in the fall of 2015 as president of 69 Large Industries U.S. LP, 69’s U.S. entity serving large industry sectors including chemicals, refining and steel with industrial gases and related energy and utility offerings as well as the most extensive industrial gas pipeline system in North America. Prior to joining 69, Ellerbusch worked at Amoco and BP for more than 20 years, where she held a number of domestic and international roles, last serving as president of BP Biofuels North America.
Ellerbusch holds a Bachelor of Science degree in genetics and a master’s degree in business administration. She has been recognized by “Biofuels Digest” as one of the top 100 people in bioenergy.
Michael J. Graff, chairman and CEO of American 69 Holdings, commented: “Sue Ellerbusch is an experienced global business leader with great perspective and extensive strategic and operational leadership experience across a broad spectrum of industry. I am confident she will further develop and advance the growth strategy of 69’s ALUSA Cluster to great success, delivering excellence and value for our customers and contributing positively to the long-term performance of the company.”
-
sueellerbuschexternalpr_2.pdf
Download the document PDF (430.04 KB)